4004.SR
4004.SR
SA135G51UI10
Dallah Healthcare Co.
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 52/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±28.7% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (-0.5x).

Beta (Market Relation)
-0.47x
Defensive
Volatility (5Y p.a.)
28.7% p.a.
5-Year Horizon
Max Drawdown (5Y)
-52.8%
5-Year Horizon
Sharpe Ratio
0.12
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -37.6%
3 Years 27.6% -52.8% -0.54 -12.4%
5 Years 28.7% -52.8% 0.12 +5.5%
10 Years 27.7% -56.0% 0.14 +6.3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -56.0% in the extended horizon.
ende